Original Research

Applying the 5-D Itch Scale to Assess Burning Sensation in Oral Lichen Planus: A Short Report from a Randomized Trial Comparing Platelet-Rich Plasma and Triamcinolone Acetonide

DOI https://doi.org/10.70302/jpsim.v7i4.2662
Received: 20 Nov 2026 Accepted: 20 Nov 2026 Published Online: 20 Nov 2026

Abstract

Objective:

This study aims to assess whether the 5D-Itch scale can be assessed in patients with OLP.

Methodology:

We applied the 5-D Itch Scale, a multidimensional instrument validated for dermatologic pruritus but not previously reported in OLP, alongside VAS in a randomized trial of 78 patients with symptomatic OLP receiving intralesional platelet-rich plasma (PRP) or triamcinolone acetonide (TA).

Results:

Both instruments produced comparable scores at baseline and at 1 week, and both independently detected significantly greater improvement with PRP by 2 weeks (5-D: 8.05 ± 1.12 vs 8.92 ± 0.98, p< 0.001; VAS: 1.79 ± 0.77 vs 2.77 ± 1.66, p= 0.002).

Conclusion:

The concordant time-course across two conceptually distinct instruments supports the responsiveness of the 5-D Itch Scale in oral mucosal disease and its ability to capture symptom dimensions- duration, disability, distribution- that intensity-only scales omit, and it appears to warrant formal validation in OLP populations.

Keywords:
Oral lichen planus 5-D Itch Scale Burning Sensation Platelet-Rich Plasma

How to Cite This Article

Balouch SS, Zahra FT, Sajid MI. Applying the 5-D Itch Scale to Assess Burning Sensation in Oral Lichen Planus: A Short Report from a Randomized Trial Comparing Platelet-Rich Plasma and Triamcinolone Acetonide. J Pak Soc Intern Med. 2026;7(4):312–314. doi:10.70302/jpsim.v7i4.2662

⭳ Download XML (JATS)

Conflict of Interest

The authors declare no conflict of interest.

Disclosed in accordance with ICMJE and COPE guidelines.

Funding

This research received no specific grant from any funding agency.

Funder information follows the Crossref Funder Registry standard.

Author Contributions

SSB: Conception.
MIS: Design of the work.
FTZ: Data acquisition, analysis, or interpretation.
FTZ, MIS: Draft the work.
SSB: Review critically for important intellectual content.
All authors approve the version to be published.
All authors agree to be accountable for all aspects of the work.

Contributions are recorded against the ICMJE criteria for authorship.

Data Availability

Data are available from the corresponding author on reasonable request.

Ethics Statement

This study was approved by Institutional Review Board, King Edward Medical University, Lahore. Approval number: 856/RC/KEMU, dated November 30, 2024.

Conducted in accordance with the Declaration of Helsinki.

References

  1. Didona D, Caposiena Caro RD, Sequeira Santos AM, Solimani F, Hertl M. Therapeutic strategies for oral lichen planus: state of the art and new insights. Front Med. 2022;9:997190.
  2. González-Moles MÁ, Warnakulasuriya S, González-Ruiz I, González-Ruiz L, Ayén Á, Lenouvel D, et al. Worldwide prevalence of oral lichen planus: a systematic review and meta-analysis. Oral Dis. 2021;27(4):813-28.
  3. Lee YC, Shin SY, Kim SW, Eun YG. Intralesional injection versus mouth rinse of triamcinolone acetonide in oral lichen planus: a randomized controlled study. Otolaryngol Head Neck Surg. 2013;148(3):443-9.
  4. ElGhareeb MI, Ghoneimy S, Elsayed A. Intralesional injection of platelet-rich plasma versus steroid in the treatment of oral lichen planus. J Cosmet Dermatol. 2023;22(5):1481-7.
  5. Elman S, Hynan LS, Gabriel V, Mayo MJ. The 5-D itch scale: a new measure of pruritus. Br J Dermatol. 2010;162(3):587-93.
  6. Ständer S, Augustin M, Reich A, Blome C, Ebata T, Phan NQ, et al. Pruritus assessment in clinical trials: consensus recommendations from the International Forum for the Study of Itch (IFSI) special interest group scoring itch in clinical trials. Acta Derm Venereol. 2013;93(5):509-14.
  7. Bennardo F, Liborio F, Barone S, Antonelli A, Buffone C, Fortunato L, et al. Efficacy of platelet-rich fibrin compared with triamcinolone acetonide as injective therapy in the treatment of symptomatic oral lichen planus: a pilot study. Clin Oral Investig. 2021;25(6):3747-55.
  8. Maddheshiya N, Srivastava A, Rastogi V, Shekhar A, Sah N, Kumar A. Platelet-rich plasma protein as a therapeutic regimen for oral lichen planus: an evidence-based systematic review. Natl J Maxillofac Surg. 2023;14(1):22-6.

Reference list indexed for Google Scholar and ResearchGate. DOI links resolve via doi.org.

CC BY CC BY 4.0 This article is published under the Creative Commons Attribution 4.0 International License. May be shared and adapted with attribution. Authors retain copyright. © 2026 The Author(s).